ADPT insiders

15 insiders have filed at ADPT since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Robins Chad MCEO And Chairman2.30M1.48%23 sells $31.3M
Robins Harlan SChief Scientific Officer1.52M0.979%14 sells $9.6M
Peterson TychoChief Financial Officer531.6k0.342%1 sells $53k
Rubinstein JuliePresident And COO455.9k0.293%29 sells $8.7M
Bobulsky SusanChief Commercial Officer, Mrd427.8k0.275%4 sells $771k
Lo FrancisChief People Officer293.9k0.189%10 sells $4.5M
Benzeno SharonChief Commercial Ofc Imm Med272.8k0.175%8 sells $11.6M
Piskel KyleChief Financial Officer259.8k0.167%12 sells $3.7M
Neupert Peter MDirector240.3k0.155%1 sells $71k
Sood NitinChief Commercial Officer, Mrd214.8k0.138%2 sells $107k
Taylor Stacy LSVP And General Counsel139.4k0.09%3 sells $167k
Owen Katey EinterzDirector88.3k0.057%
Pellini Michael JDirector69.7k0.045%
Hershberg RobertDirector62.3k0.04%2 sells $770k
Griffin Michelle ReneeDirector15.6k0.01%4 sells $1.3M

Full register at boothcheck.com/insiders/ADPT. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

ADPT institutional holders · ADPT research report